Does severe ADAMTS13 deficiency in thrombotic microangiopathy rule out complement-mediated atypical hemolytic uremic syndrome

Does severe ADAMTS13 deficiency in thrombotic microangiopathy rule out complement-mediated atypical hemolytic uremic syndrome

In evaluating a patient with thrombotic microangiopathy (TMA), it is necessary to rule out thrombotic thrombocytopenic purpura before a diagnosis of atypical hemolytic uremic syndrome (aHUS) is made. There have been reports that mutations of complement factors can coexist with partial A Disintegrin...

Full description

Bibliographic Details
Main Authors: Venkatesh Arumugam, Rohit Bhowmick, Indira Agarwal, Manjusha Arumadi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2019;volume=30;issue=3;spage=701;epage=705;aulast=Arumugam

Internet

http://www.sjkdt.org/article.asp?issn=1319-2442;year=2019;volume=30;issue=3;spage=701;epage=705;aulast=Arumugam

Similar Items